These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 27245695
1. Effects of telmisartan and pioglitazone on high fructose induced metabolic syndrome in rats. Shahataa MG, Mostafa-Hedeab G, Ali EF, Mahdi EA, Mahmoud FA. Can J Physiol Pharmacol; 2016 Aug; 94(8):907-17. PubMed ID: 27245695 [Abstract] [Full Text] [Related]
2. Comparative effects of Aliskiren and Telmisartan in high fructose diet-induced metabolic syndrome in rats. Rabie EM, Heeba GH, Abouzied MM, Khalifa MM. Eur J Pharmacol; 2015 Aug 05; 760():145-53. PubMed ID: 25917321 [Abstract] [Full Text] [Related]
3. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome. Kagota S, Tada Y, Nejime N, Nakamura K, Kunitomo M, Shinozuka K. Can J Physiol Pharmacol; 2011 May 05; 89(5):355-64. PubMed ID: 21619437 [Abstract] [Full Text] [Related]
4. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. Kelany ME, Hakami TM, Omar AH. Can J Physiol Pharmacol; 2017 Feb 05; 95(2):140-150. PubMed ID: 27901349 [Abstract] [Full Text] [Related]
6. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha. Derosa G, Cicero AF, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Ferrari I, Gravina A, Fogari R. Hypertens Res; 2006 Nov 05; 29(11):849-56. PubMed ID: 17345784 [Abstract] [Full Text] [Related]
11. Melatonin improves metabolic syndrome induced by high fructose intake in rats. Kitagawa A, Ohta Y, Ohashi K. J Pineal Res; 2012 May 05; 52(4):403-13. PubMed ID: 22220562 [Abstract] [Full Text] [Related]
12. Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose. Wohl P, Krusinová E, Hill M, Kratochvílová S, Zídková K, Kopecký J, Neskudla T, Pravenec M, Klementová M, Vrbíková J, Wohl P, Mlejnek P, Pelikánová T. Eur J Endocrinol; 2010 Oct 05; 163(4):573-83. PubMed ID: 20630944 [Abstract] [Full Text] [Related]
13. Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886. Kusunoki M, Tsutsumi K, Sato D, Nakamura A, Habu S, Mori Y, Morishita M, Yonemoto T, Miyata T, Nakaya Y, Nakamura T. Eur J Pharmacol; 2011 Oct 15; 668(3):486-91. PubMed ID: 21835171 [Abstract] [Full Text] [Related]
19. Effect of a deacyl gymnemic acid on glucose homeostasis & metabolic parameters in a rat model of metabolic syndrome. Bhansali S, Shafiq N, Pandhi P, Singh AP, Singh I, Singh PK, Sharma S, Malhotra S. Indian J Med Res; 2013 Jun 15; 137(6):1174-9. PubMed ID: 23852298 [Abstract] [Full Text] [Related]